Log In | Fax Order | Shopping Cart  
 
 Home  Products Services Career Distributors Contact Us     240-454-9768          
Services
Protein Expression
Genome Engineering
Adenovirus Service
Custom Cloing
Virus Production
Antibody Production
Products
New Products
PCR & qPCR
Cancer Proteins
Protein Kinases
Stem Cell Reagents
Enzymes
Recombinant Proteins
Premade Adenovirus
Premade AAV
Premade Lentivirus
Lentivirus Controls
Kinase Lentivirus
Kinase Retrovirus
Kinase Adenovirus
Kinase AAV
Transcription Factors
Transfection
Order History
  • Track Your Orders
Adenovirus Service

 Previous 
 Return to List 
 Next 

AdExpressTM RCA-free Adenovirus Amplification

Catalog #: RCAFreeAd



Call for price


RCA-free Adenovirus Amplification Service using 293RCA- Packaging Cell Line

 

Excellgen's 293RCA- cell line is an E1-complementing cell line that eliminates the occurrence of Replication Competent Adenoviruses (RCA). First generation E1-deleted recombinant adenoviruses are typically propagated in complementing Human Embryonic Kidney HEK-293 cell line which stably expresses the E1 gene products (Graham et al., 1977). RCAs are known to occur after several passages of amplification in HEK-293 cells. RCAs emerge following a double crossover event between the homologous overlapping sequences in the rAd genome and the E1 genes from the 293 cells, resulting in the loss of transgene and its replacement by E1 (Lochmüller et al., 1994, Hehir et al., 1996, Zhu et al., 1999). The presence of RCAs in adenovirus stocks could have deleterious effects to the cells when used in gene delivery experiments in vitro, could be harmful to animals used for in vivo studies and pose potential risks to patients by activating the immune system or by acting as helper viruses for the replication of attenuated viral vectors (Imler et al., 1995).

 

The 293RCA- cell line was engineered by Excellgen and Feldan to express the E1 genes without overlapping sequences with the adenovirus backbone (such as AdEasy™), thus eliminating the risk of generating RCAs in viral stocks. The new  293RCA- cell line provides scientists involved in functional genomics studies, gene delivery and gene therapy research with better control over RCAs in their viral stocks.

 

Features

· No homologous sequences with adenoviral backbones

· No risk of occurrence of RCA contaminants

· Affordable alternative for RCA-free cultures

 

Services available with the 293RCA- cell line

· Recombinant Adenovirus construction

· Plaque purification

· Amplification

· Purification

· Titration

· RCA detection: PCR- and cell-based

 

References

Hehir et al. 1996. Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence. J. Virol. 70: 8459-8467.

Imler et al. 1995. Trans-complementation of E1-deleted adenovirus: A new vector to reduce the possibility of codissemination of wild-type and recombinant adenoviruses. Hum. Gen. Ther. 6: 711-721.

Lochmller et al. 1994. Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants (dE1 dE3) during multiple passages in 293A cells. Hum. Gene Ther. 5: 1485-1491.

Zhu et al. 1999. Characterization of replication-competent adenovirus isolates from large-scale production of a recombinant adenoviral vector. Hum. Gene Ther. 10:113-121.


 
 Tell a Friend 
 
 Write a Review 
 
 Price Quote 
 
 Home | Privacy Policy | Terms & Conditions | Online Price Policy | Shipping & Return | Contact Us | All Products

Copyright © 2007-2012  Excellgen, Inc. All rights reserved